無針薬剤注射システムの世界市場

当レポートでは、世界の無針薬剤注射システム市場について調査し、市場の概要と2022年までの予測、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

• 業界概要
  • 無針薬剤注射システム：概要
  • 無針ドラッグデリバリーシステム：概要
  • 長所
  • 短所
  • 市場動向
  • 市場促進因子と障壁
  • 高齢化が市場を促進
  • 医療費拡大が成長を促進
  • 世界の癌罹患率統計
  • 治療への応用拡大が成長の機会を生む
  • 競合シナリオ
  • 次世代無針ジェット技術
  • 様々なステークホルダーへのメリット
  • 応用
  • 現在の発展動向　他
• 将来の応用
  • 不活化ポリオワクチン
  • インフルエンザワクチン
  • MMRワクチン（麻疹、おたふく風邪、風疹）
  • BCGワクチン
  • 黄熱病ワクチン
  • E.DTP・ヒブ・B型肝炎ワクチン
  • 狂犬病ワクチン
  • インスリン治療
  • その他
• ドラッグデリバリーシステム：概要
• 製品概要
• 近年の業界活動
• 主要企業
  • AKRA Dermojet
  • Crossject SA
  • D'Antonio Consultants International, Inc.
  • Medical International Technologies, Inc.
  • National Medical Products, Inc.
  • PharmaJet
  • Zogenix, Inc
• 世界市場見通し

第3章 市場

• 米国
• カナダ
• 日本
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• その他の諸国

This report analyzes the worldwide markets for Needle-Free Drug Injection Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 62 companies including many key and niche players such as -

AKRA Dermojet
Crossject SA
DAntonio Consultants International, Inc.
Medical International Technologies, Inc.
National Medical Products, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

• Needle-Free Drug Injection Systems: An Overview
• Needle-Free Drug Delivery Systems: An Overview
• Brief Glance of Needle-Free Drug Delivery Systems
• Advantages
• Disadvantages
• Needle-Free Drug Injection System: Market Dynamics
• Drivers and Barriers of Needle-free Drug Injection Systems Market
• Increasing Geriatric Population to Drive Market
• Table 1: Global Aging Population (in Thousands) by Age Group: 1975, 2000 & 2025P (includes corresponding Graph/Chart)
• Table 2: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
• Table 3: Life Expectancy for Select Countries in Number of Years (2015) (includes corresponding Graph/Chart)
• Improving Healthcare Expenditure to Foster Growth
• Table 4: Healthcare Spending as % of GDP by Region (2016) (includes corresponding Graph/Chart)
• Table 5: Healthcare Spending as a Percentage of GDP in Select Countries (2013) (includes corresponding Graph/Chart)
• Table 6: Per-Capita Healthcare Spending in US$ for Select Countries (2013) (includes corresponding Graph/Chart)
• Increasing Incidence of Cancer Bodes Well for Needle-free Drug Injection Systems
• Global Cancer Prevalence Statistics - Opportunity Indicators
• Table 7: Worldwide Incidence of Cancer (2012, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
• Table 8: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
• Table 9: New Cancer Cases in the World in Thousands by Affected Site (2012) (includes corresponding Graph/Chart)
• Expanding Therapeutic Applications to Generate Growth Opportunities
• Competitive Scenario
• Needle-free Jet Injections: Future Burning Bright
• Growth Factors
• Next Generation Needle-free Jet Technologies
• Advantageous to Different Stakeholders
• Applications
• Formulation Challenges
• Current Development Status
• The Road Ahead
• Innovations in Needle-Free Drug Injection System Technology
• Needle-free Arterial Non-Injectable Connector
• Pulsed Micro Jets

2. FUTURE APPLICATIONS

• Inactivated Polio Vaccine
• Influenza Vaccine
• Measles-Mumps-Rubella Vaccine
• BCG Vaccine
• Yellow Fever Vaccine
• E. DTP-Hib-hep B Vaccine
• Rabies Vaccine
• Insulin Therapy
• Others

3. DRUG DELIVERY SYSTEMS - AN OVERVIEW

• Oral Vaccines
• Nasal Sprays, Suppositories and Eye and Nose Drops
• Inhalers
• Select Vaccine Inhalers in Development Stage (2016)
• Transdermal
• Injected Fine Mist or Powder
• Jet Injectors
• Iontophoretic Transdermal
• Patches
• Microneedles
• Implants

4. PRODUCT OVERVIEW

5. RECENT INDUSTRY ACTIVITY

• PharmaJet(r) Adds Trivalent and Quadrivalent Influenza Vaccine to Injector System
• Eternity Healthcare's Lenis(r) Device Bags CE Certification
• PharmaJet(r) Inks Deal With Serum Institute to Launch Needle-free MMR Vaccine
• Inovio Pharmaceuticals Acquires BioJect Medical Technologies
• PharmaJet(r) Partners With Vaccibody for HPV Vaccine Development
• Zika Virus DNA Vaccine Clinical Trial Being Conducted With PharmaJet Needle-free Device
• PharmaJet Inks Partnership Agreement with Distributors for Marketing PharmaJet(r) Across the US
• Antares Pharma Bags FDA Approval for ZOMACTON(tm) and ZOMAJet(tm)
• Portal Instruments Raises US$25 million in Series B Financing
• West Pharmaceutical Services Bags 510(k) Clearance for Needle-stick Guards
• Crossject Develops Needle-Free Injection System - The ZENEO Device
• FDA Grants Approval for Stratis Needle-Free Injection System
• Portal Instruments(r) Raises US$11 million from Sanofi

6. FOCUS ON SELECT PLAYERS

• AKRA Dermojet (France)
• Crossject SA (France)
• D'Antonio Consultants International, Inc. (USA)
• Medical International Technologies, Inc. (Canada)
• National Medical Products, Inc. (USA)
• PharmaJet (USA)
• Zogenix, Inc. (USA)

7. GLOBAL MARKET PERSPECTIVE

• Table 10: World Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 11: World Historic Review for Needle-Free Drug Injection Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
• Table 12: World 14-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region - Percentage Breakdown of Dollar Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

• A. Market Analysis
• Market Overview
• Strategic Corporate Developments
• Select Players
• B. Market Analytics
• Table 13: US Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 14: US Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA

• A. Market Analysis
• Market Overview
• Strategic Corporate Development
• Medical International Technologies, Inc. - A Key Canadian Player
• B. Market Analytics
• Table 15: Canadian Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 16: Canadian Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. JAPAN

• Market Analysis
• Table 17: Japanese Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 18: Japanese Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. EUROPE

• Market Analysis
• Table 19: European Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 20: European Historic Review for Needle-Free Drug Injection Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
• Table 21: European 14-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region - Percentage Breakdown of Dollar Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE

• A. Market Analysis
• Market Overview
• Strategic Corporate Development
• Select Players
• B. Market Analytics
• Table 22: French Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 23: French Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4b. GERMANY

• Market Analysis
• Table 24: German Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 25: German Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4c. ITALY

• Market Analysis
• Table 26: Italian Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 27: Italian Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4d. UNITED KINGDOM

• Market Analysis
• Table 28: UK Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 29: UK Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4e. SPAIN

• Market Analysis
• Table 30: Spanish Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 31: Spanish Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4f. RUSSIA

• Market Analysis
• Table 32: Russian Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 33: Russian Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

• Market Analysis
• Table 34: Rest of Europe Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 35: Rest of Europe Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

• Market Analysis
• Table 36: Asia-Pacific Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 37: Asia-Pacific Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. LATIN AMERICA

• Market Analysis
• Table 38: Latin American Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 39: Latin American Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

7. REST OF WORLD

• Market Analysis
• Table 40: Rest of World Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
• Table 41: Rest of World Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)